Mycoplasma genitalium and antimicrobial resistance in Europe: a comprehensive review-Reference-Cited by-同舟云学术

Mycoplasma genitalium and antimicrobial resistance in Europe: a comprehensive review

Published:2020-01-30 Issue:3 Volume:31 Page:190-197
ISSN:0956-4624
Container-title:International Journal of STD & AIDS
language:en
Short-container-title:Int J STD AIDS

Author:

Fernández-Huerta Miguel¹,Barberá María J²,Serra-Pladevall Judit¹,Esperalba Juliana¹,Martínez-Gómez Xavier³,Centeno Cristina⁴^ORCID,Pich Oscar Q⁵⁶,Pumarola Tomàs¹,Espasa Mateu⁵^ORCID

Affiliation:

1. Microbiology Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

2. Sexually Transmitted Infections Unit Vall d’Hebron-Drassanes, Infectious Diseases Department, Vall d’Hebron University Hospital, University of Barcelona, Barcelona, Spain

3. Epidemiology Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

4. Gynecology Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

5. Microbiology Department, Parc Taulí University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

6. Institute of Biotechnology and Biomedicine and Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona, Spain

Abstract

Antibiotic resistance in Mycoplasma genitalium has been emerging in Europe. Also, discrepancies on the management and treatment of sexually transmitted infections may have distinctly influenced the prevalence of antimicrobial resistance among European countries. This comprehensive review of the literature published between 2012 and 2018 updates antimicrobial resistance data in M. genitalium in Europe. Overall, macrolide resistance is rapidly increasing in this region, where many countries are exceeding 50%. The limited data regarding fluoroquinolone resistance estimate a prevalence of 5% (interquartile range, 5–6%). The study supports the need to conduct representative and well-defined surveillance on antimicrobial resistance in M. genitalium at both local and European levels. Also, further investigations on new promising antibiotics are required to fight against M. genitalium that may soon become untreatable.

Publisher

SAGE Publications

Subject

Infectious Diseases,Pharmacology (medical),Public Health, Environmental and Occupational Health,Dermatology

Link

http://journals.sagepub.com/doi/pdf/10.1177/0956462419890737

Reference41 articles.

1. Mycoplasma genitalium: from Chrysalis to Multicolored Butterfly

2. Standard Treatment Regimens for Nongonococcal Urethritis Have Similar but Declining Cure Rates: A Randomized Controlled Trial

3. Background review for the 2016 European guideline on Mycoplasma genitalium infections

4. The Efficacy of Azithromycin for the Treatment of GenitalMycoplasma genitalium: A Systematic Review and Meta-analysis

5. Azithromycin Treatment Failure inMycoplasma genitalium–Positive Patients with Nongonococcal Urethritis Is Associated with Induced Macrolide Resistance

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mycoplasma genitaliumtreatment outcomes among a cohort failing macrolide resistance-guided treatment across three London sexual health clinics;Sexually Transmitted Infections;2024-08-01

2. Treating Mycoplasma genitalium (in pregnancy): a social and reproductive justice concern;Monash Bioethics Review;2024-07-11

3. Investigating the cause of increased tetracycline-resistant Neisseria gonorrhoeae in England, 2016–20;Journal of Antimicrobial Chemotherapy;2024-03-22

4. Evolving Patterns of Macrolide and Fluoroquinolone Resistance in Mycoplasma Genitalium: An Updated Global Systematic Review and Meta-Analysis;2024

5. A multi-strategy antimicrobial discovery approach reveals new ways to combatChlamydia;2023-11-30